PRINTER'S NO. 2399
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
441
Session of
2019
INTRODUCED BY SCHLEGEL CULVER, PICKETT, CALTAGIRONE, BIZZARRO,
WILLIAMS, LONGIETTI, DiGIROLAMO, KORTZ, YOUNGBLOOD, BROWN,
PYLE, BURNS, FLYNN, READSHAW, RYAN, MILLARD, HILL-EVANS,
KINSEY AND GILLEN, SEPTEMBER 3, 2019
REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 3, 2019
A RESOLUTION
Designating the month of September 2019 as "Histiocytosis
Awareness Month" in Pennsylvania.
WHEREAS, Histiocytosis is a general name for a group of rare
disorders that involve an abnormal increase in the number of
specialized white blood cells that are called histiocytes; and
WHEREAS, In 1987, the Histiocyte Society first classified
this group of disorders into three categories; and
WHEREAS, The first category, dendritic cell disorder,
includes Langerhans cell histosis, juvenile xanthogranuloma and
Erdheim-Chester disease; and
WHEREAS, The second category, macrophage cell disorder,
includes hemophagocytic lymphohistiocytosis and Rosai-Dorfman
disease; and
WHEREAS, The third category, malignant histiocytosis,
includes certain kinds of leukemia and malignant tumors; and
WHEREAS, There are multiple competing classification systems,
including a proposed five-category system; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
WHEREAS, Chemotherapy is a common treatment for histiocytosic
disorders; and
WHEREAS, Histiocytosic disorders can affect children or
adults, and more research is needed to help those impacted by
the disorders; therefore be it
RESOLVED, That the House of Representatives designate the
month of September 2019 as "Histiocytosis Awareness Month" in
Pennsylvania.
20190HR0441PN2399 - 2 -
1
2
3
4
5
6
7
8